where clinical endpoints are used (e.g., CIPN severity, skin lightening), findings are mixed and often context-specific
In these cases, adding other peptides targeting different mechanisms, implementing intermittent fasting protocols, or increasing activity levels often proves more effective than further dose increases
In dexamethasone-induced rat VSMCs circadian gene expression models, L-theanine treatment showed that the expression of clock genes Bmal1, Cry1, Reverb alpha, and Per2 increased (83)
By combining GLP-1, GIP, and glucagon receptor agonism, retatrutide simultaneously reduces energy intake, increases energy expenditure, and corrects insulin resistance and lipid flux
That model is not unique